Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page .
HC Wainwright & Co. raised Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ) price target from $48 to $62. HC Wainwright & Co. analyst Emily Bodnar maintained a Buy rating. Agios Pharmaceuticals shares closed at $29.17 on Wednesday. See how other analysts view this stock . HC Wainwright & Co. cut the price target for Lexaria Bioscience Corp. (NASDAQ: LEXX ) from $4 to $1.5. HC Wainwright & Co. analyst Yi Chen maintained a Buy rating. Lexaria Bioscience shares closed at $0.56 on Wednesday. See how other analysts view this stock. Leerink Partners increased Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ) price target from $34 to $40. Leerink Partners analyst Andrew Berens maintained an Outperform rating. Agios Pharmaceuticals shares closed at $29.17 on Wednesday. See how other analysts view this stoc k. BTIG raised the price target for Capital One Financial Corporation (NYSE: COF ) from $264 to $308. BTIG analyst Vincent Caintic maintained a Buy rating. Capital One Financial shares closed at $248.27 on Wednesday. See how other analysts view this stock.Considering buying COF stock? Here’s what analysts think:
Read This Next:
Wall Street’s Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 7% Dividend YieldsPhoto via Shutterstock
AGIO Agios Pharmaceuticals Inc $27.72 -4.97% Overview COF Capital One Financial Corp $248.30 0.01% LEXX Lexaria Bioscience Corp $0.5450 -2.69% Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Add Comment | 1Posted In: News Price Target Markets Analyst Ratings Trading Ideas analysts forecasts PT Changes